Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus

被引:91
作者
Invernizzi, R [1 ]
Velasco, C [1 ]
Bramante, M [1 ]
Longo, A [1 ]
Samanin, R [1 ]
机构
[1] IST RIC FARMACOL MARIO NEGRI, MILAN, ITALY
关键词
5-HT1A receptor; 5-HT1B receptor; SSRI; dorsal hippocampus; frontal cortex; striatum; dialysate; 5-HT; antidepressant activity; microdialysis;
D O I
10.1016/S0028-3908(97)00060-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of the present study was to compare the effects of citalopram, either alone or combined with 5-HT1A receptor antagonists, on extracellular serotonin levels in brain regions innervated by the dorsal or median raphe nuclei. Using intracerebral microdialysis in awake rats with separate probes in the frontal cortex or dorsal hippocampus, we studied the ability of 8 mg/kg s.c. (-)penbutolol, a beta-adrenoceptor antagonist with antagonist action at 5-HT1A and 5-HT1B receptors, and 0.3 mg/kg s.c. WAY-100635, a selective 5-HT1A receptor blocker, to modify the effect of 1 and 10 mg/kg i.p. citalopram on extracellular serotonin. Both doses of citalopram had more effect on extracellular serotonin levels in the dorsal hippocampus than in the frontal cortex. The effect of 1 mg/kg citalopram was significantly potentiated by (-)penbutolol in the frontal cortex only, but a clear-cut potentiation of the effect of citalopram was seen in both regions at a dose of 10 mg/kg. The effect of 10 mg/kg citalopram was potentiated by WAY-100635 in the frontal cortex but not in the dorsal hippocampus. In a second set of experiments, the combined effect of WAY-100635 and citalopram was studied in the same rat implanted with vertical probes in the striatum and dorsal hippocampus. Citalopram (1 and 10 mg/kg i.p.) raised extracellular serotonin to a similar extent in both regions. However, 0.3 mg/kg s.c. WAY-100635 potentiated the effect of 10 mg/kg citalopram in the striatum but not in the dorsal hippocampus. The results suggest that only a combined blockade of 5-HT1A and 5-HT1B receptors potentiates the effect of citalopram on extracellular concentrations of serotonin in the dorsal hippocampus. The findings may be relevant in designing clinical trials aimed at enhancing the antidepressant action of selective serotonin re-uptake inhibitors by combining them with serotonin receptor antagonists. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:467 / 473
页数:7
相关论文
共 34 条
[1]  
ADELL A, 1991, N-S ARCH PHARMACOL, V343, P237
[2]   The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram [J].
Arborelius, L ;
Nomikos, GG ;
Hertel, P ;
Salmi, P ;
Grillner, P ;
Hook, BB ;
Hacksell, U ;
Svensson, TH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (06) :630-640
[3]   Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists [J].
Artigas, F ;
Romero, L ;
deMontigny, C ;
Blier, P .
TRENDS IN NEUROSCIENCES, 1996, 19 (09) :378-383
[4]  
ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248
[5]   5-HT AND ANTIDEPRESSANTS - NEW VIEWS FROM MICRODIALYSIS STUDIES [J].
ARTIGAS, F .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (07) :262-262
[6]   AUTORADIOGRAPHIC ANALYSIS OF DIFFERENTIAL ASCENDING PROJECTIONS OF DORSAL AND MEDIAN RAPHE NUCLEI IN RAT [J].
AZMITIA, EC ;
SEGAL, M .
JOURNAL OF COMPARATIVE NEUROLOGY, 1978, 179 (03) :641-667
[7]  
BEL N, 1994, MONITORING MOLECULES IN NEUROSCIENCE, P209
[8]  
Berman RM, 1997, AM J PSYCHIAT, V154, P37
[9]   EFFECTIVENESS OF PINDOLOL WITH SELECTED ANTIDEPRESSANT DRUGS IN THE TREATMENT OF MAJOR DEPRESSION [J].
BLIER, P ;
BERGERON, R .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (03) :217-222
[10]   EFFECTS OF SINGLE AND REPEATED ORAL-ADMINISTRATION OF FLUVOXAMINE ON EXTRACELLULAR SEROTONIN IN THE MEDIAN RAPHE NUCLEUS AND DORSAL HIPPOCAMPUS OF THE RAT [J].
BOSKER, FJ ;
KLOMPMAKERS, AA ;
WESTENBERG, HGM .
NEUROPHARMACOLOGY, 1995, 34 (05) :501-508